Dr Martens has reached an adjusted profit before tax of £55m in the year to 29 March, marking a 61.3% annual reported increase.

The footwear retailer stated that in this period, its earnings jumped by 30.6% to £79.3m, while its revenue landed in line with guidance, falling by 2.9% to £764.9m.

Dr Martens said its 2026 financial year was "centred on pivoting the business to being truly consumer-first", after it "successfully stabilised" the business in FY25.

Across the company, its Americas division was the best performing region, as full price direct to customer revenues jumped 14%, while this figure fell by 13% in its EMEA region, despite "good wholesale growth".

Chief executive officer at Dr Martens, Ije Nwokorie, said: "In FY26 we returned the business to profit growth, delivering a 61% increase in adjusted PBT, with revenue in line with guidance, and made good progress pivoting the business to a consumer first operating model. Shoes were the standout performer, up 19%.

"Our focus on execution is paying off: we are improving the quality of revenues whilst strengthening margins, cash generation, the balance sheet and overall model resilience."

In its outlook, Dr Martens said that while there is more work to do in pivoting the business, it will enter the scale phase of its strategy.

The firm said this does not mean volume at any costs, but rather scaling higher-quality revenues and operational leverage, "underpinned by a more resilient model".

The retailer expects further strong profit growth in FY27, driven by operational leverage. It added that it has good visibility of its supply chain costs for the rest of the year.

While it said it's currently navigating an "unpredictable trading environment", as geopolitical uncertainty impacts consumer confidence, it is focused on executing its strategy.

Following the announcement, shares in Dr Martens jumped by almost 6%.

Investment director at AJ Bell, Russ Mould, concluded: "Dr Martens found its feet after a wobbly patch for the company. Profit growth is back on the menu and there is a more optimistic tone from management. There is a lot more work to be done as it tries to build scale and deal with an uncertain economic backdrop.

"Dr Martens’ shoes aren’t a casual purchase, and consumers might prioritise essentials if life gets harder because of inflationary pressures and interest rates potentially going up."

---